Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Solengepras

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cerevance To Unveil Positive Phase 2 Solengepras Data
    Cerevance To Unveil Positive Phase 2 Solengepras Data

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270868/0/en/Cerevance-to-Present-Positive-Phase-2-Solengepras-Data-in-Parkinson-s-Disease-at-the-American-Academy-of-Neurology-2026-Annual-Meeting.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Cerevance To Unveil Solengepras Phase 2 Results In Parkinson
    Cerevance To Unveil Solengepras Phase 2 Results In Parkinson

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252742/0/en/Cerevance-to-Present-Phase-2-Trial-Results-on-OFF-Time-and-Sleep-Related-Outcomes-with-Solengepras-in-Parkinson-s-Disease-at-AD-PD-2026.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    A New Era in Parkinson’s: Solengepras Shifts Beyond Dopamine
    A New Era in Parkinson’s: Solengepras Shifts Beyond Dopamine

    09 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/sponsored/new-era-parkinsons-solengepras-leads-shift-beyond-dopamine

    FIERCE BIOTECH
    09 Dec 2025
    Share Share
    Cerevance To Showcase Solengepras In Parkinson's At PSG Meeting
    Cerevance To Showcase Solengepras In Parkinson's At PSG Meeting

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193435/0/en/Cerevance-to-Highlight-Potential-of-Solengepras-in-Parkinson-s-Disease-at-the-2025-Parkinson-Study-Group-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Cerevance To Unveil Solengepras Phase 2 Data For Parkinson's
    Cerevance To Unveil Solengepras Phase 2 Data For Parkinson's

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153862/0/en/Cerevance-to-Present-Phase-2-Data-on-Solengepras-in-Parkinson-s-Disease-at-the-2025-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.